Skip to content
2000
Volume 24, Issue 5
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Pulmonary fibrosis is a class of fibrosing interstitial lung diseases caused by many pathogenic factors inside and outside the lung, with unknown mechanisms and without effective treatment. Therefore, a comprehensive understanding of the molecular mechanism implicated in pulmonary fibrosis pathogenesis is urgently needed to develop new and effective measures. Although circRNAs have been widely acknowledged as new contributors to the occurrence and development of diseases, only a small number of circRNAs have been functionally characterized in pulmonary fibrosis. Here, we systematically review the biogenesis and functions of circRNAs and focus on how circRNAs participate in pulmonary fibrogenesis by influencing various cell fates. Meanwhile, we analyze the current exploration of circRNAs as a diagnostic biomarker, vaccine, and therapeutic target in pulmonary fibrosis and objectively discuss the challenges of circRNA- based therapy for pulmonary fibrosis. We hope that the review of the implication of circRNAs will provide new insights into the development circRNA-based approaches to treat pulmonary fibrosis.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/0115665232284076240207073542
2024-10-01
2024-10-11
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/0115665232284076240207073542
Loading
  • Article Type: Review Article
Keyword(s): biogenesis; biomarker; circRNA; circRNA-based therapy; Pulmonary fibrosis; vaccine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test